These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 28506728

  • 1. [The effects of inhaled steroids withdrawal in COPD].
    Jebrak G, Honore I, Serrier P, Dumoulin J, Terrioux P, Soyez F, Maurer C, Mangiapan G, Febvre M, Couderc LJ, Braun JM, Chinet T.
    Rev Mal Respir; 2017 Oct; 34(8):820-833. PubMed ID: 28506728
    [Abstract] [Full Text] [Related]

  • 2. [The place of inhaled corticosteroids in COPD].
    Chinet T, Dumoulin J, Honore I, Braun JM, Couderc LJ, Febvre M, Mangiapan G, Maurer C, Serrier P, Soyez F, Terrioux P, Jebrak G.
    Rev Mal Respir; 2016 Dec; 33(10):877-891. PubMed ID: 26831345
    [Abstract] [Full Text] [Related]

  • 3. Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice.
    Kaplan AG.
    Int J Chron Obstruct Pulmon Dis; 2015 Dec; 10():2535-48. PubMed ID: 26648711
    [Abstract] [Full Text] [Related]

  • 4. "Correct use of inhaled corticosteroids in chronic obstructive pulmonary disease": a consensus document.
    Alcázar Navarrete B, Casanova C, Miravitlles M, de Lucas P, Riesco JA, Rodríguez González-Moro JM, Working Group “Consensus document on the appropriate use of inhaled corticosteroids in COPD”.
    Arch Bronconeumol; 2015 Apr; 51(4):193-8. PubMed ID: 25540900
    [Abstract] [Full Text] [Related]

  • 5. "Real-life" inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD.
    Vogelmeier C, Worth H, Buhl R, Criée CP, Lossi NS, Mailänder C, Kardos P.
    Int J Chron Obstruct Pulmon Dis; 2017 Apr; 12():487-494. PubMed ID: 28203072
    [Abstract] [Full Text] [Related]

  • 6. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?
    López-Campos JL, Calero Acuña C.
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):43-51. PubMed ID: 23551023
    [Abstract] [Full Text] [Related]

  • 7. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
    Yamauchi Y, Yasunaga H, Hasegawa W, Sakamoto Y, Takeshima H, Jo T, Matsui H, Fushimi K, Nagase T.
    Int J Chron Obstruct Pulmon Dis; 2016 Apr; 11():1403-11. PubMed ID: 27382276
    [Abstract] [Full Text] [Related]

  • 8. Inhaled corticosteroids for chronic obstructive pulmonary disease.
    Cazzola M, Rogliani P, Novelli L, Matera MG.
    Expert Opin Pharmacother; 2013 Dec; 14(18):2489-99. PubMed ID: 24138334
    [Abstract] [Full Text] [Related]

  • 9. Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice.
    Cataldo D, Derom E, Liistro G, Marchand E, Ninane V, Peché R, Slabbynck H, Vincken W, Janssens W.
    Int J Chron Obstruct Pulmon Dis; 2018 Dec; 13():2089-2099. PubMed ID: 30013336
    [Abstract] [Full Text] [Related]

  • 10. Use of inhaled corticosteroids in COPD: improving efficacy.
    Yang IA, Shaw JG, Goddard JR, Clarke MS, Reid DW.
    Expert Rev Respir Med; 2016 Dec; 10(3):339-50. PubMed ID: 26855301
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL, Lin CH.
    Int J Chron Obstruct Pulmon Dis; 2016 Dec; 11():2341-2348. PubMed ID: 27703344
    [Abstract] [Full Text] [Related]

  • 12. Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale.
    Magnussen H, Watz H, Kirsten A, Decramer M, Dahl R, Calverley PM, Towse L, Finnigan H, Tetzlaff K, Disse B.
    Respir Med; 2014 Apr; 108(4):593-9. PubMed ID: 24477080
    [Abstract] [Full Text] [Related]

  • 13. Pragmatic trial on inhaled corticosteroid withdrawal in patients with COPD in general practice.
    van den Bemt L, van den Nieuwenhof L, Rutjes A, van der Meer V, Stege G, Wensing M, Teichert M, Schermer T.
    NPJ Prim Care Respir Med; 2020 Oct 09; 30(1):43. PubMed ID: 33037200
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological Management of Elderly Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Room for Speculation?
    Castiglia D, Battaglia S, Benfante A, Sorino C, Scichilone N.
    Drugs Aging; 2016 Jun 09; 33(6):375-85. PubMed ID: 27138954
    [Abstract] [Full Text] [Related]

  • 15. Inappropriate inhaled corticosteroid prescribing in chronic obstructive pulmonary disease patients.
    Harrison A, Borg B, Thompson B, Hew M, Dabscheck E.
    Intern Med J; 2017 Nov 09; 47(11):1310-1313. PubMed ID: 29105270
    [Abstract] [Full Text] [Related]

  • 16. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA.
    Pulm Pharmacol Ther; 2008 Nov 09; 21(3):540-50. PubMed ID: 18280761
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug 09; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 18. [Inhaled corticosteroid/beta-2 agonist therapy in moderate COPD].
    Yıldırım N.
    Tuberk Toraks; 2010 Aug 09; 58(2):192-201. PubMed ID: 20865575
    [Abstract] [Full Text] [Related]

  • 19. An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group.
    Jarad NA, Wedzicha JA, Burge PS, Calverley PM.
    Respir Med; 1999 Mar 09; 93(3):161-6. PubMed ID: 10464871
    [Abstract] [Full Text] [Related]

  • 20. The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review.
    Andreeva-Gateva PA, Stamenova E, Gatev T.
    Postgrad Med; 2016 Jun 09; 128(5):474-84. PubMed ID: 27153510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.